Patent details

EP1773850 Title: PRODRUGS OF HIV PROTEASE INHIBITORS

Basic Information

Publication number:
EP1773850
PCT Application Number:
PCT/US/2005/023047
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057625295
PCT Publication Number:
WO/2006/014282
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PRODRUGS OF HIV PROTEASE INHIBITORS
French Title of Invention:
PROMEDICAMENTS D'INHIBITEURS DE PROTEASE DE VIH
German Title of Invention:
PRODRUGS VON HIV-PROTEASE-INHIBITOREN
SPC Number:

Dates

Filing date:
29/06/2005
Grant date:
30/01/2013
EP Publication Date:
30/01/2013
PCT Publication Date:
09/02/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/04/2007
EP B1 Publication Date:
30/01/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/06/2013
Expiration date:
29/06/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/05/2013
 
 

Name:
AbbVie Inc.
Address:
1 North Waukegan Road, North Chicago, IL 60064, United States (US)

Inventor

1

Name:
DEGOEY David, A.
Address:
United States (US)

2

Name:
KEMPF Dale, J.
Address:
United States (US)

3

Name:
GRAMPOVNIK David, J.
Address:
United States (US)

4

Name:
KLEIN Larry, L.
Address:
United States (US)

5

Name:
FLOSI William, J.
Address:
United States (US)

6

Name:
WANG Xiu, C.
Address:
United States (US)

Priority

Priority Number:
585710 P
Priority Date:
06/07/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
C07F 9/09;
Filing date Document type Number of pages